French Tech Hardware Stock News

ENXTPA:RCO
ENXTPA:RCOBeverage

Assessing Rémy Cointreau (ENXTPA:RCO) Valuation After Recent Share Price Recovery

Recent performance snapshot and what it may mean for investors Without a single defining news event driving headlines, Rémy Cointreau (ENXTPA:RCO) has still given investors plenty to consider, with mixed short term and longer term share performance across different timeframes. The stock is up about 1.5% over the past day and 4.6% over the past week. Moves over the past month and past 3 months sit around flat and 10% respectively, which may point to shifting sentiment. See our latest analysis...
ENXTPA:FRVIA
ENXTPA:FRVIAAuto Components

A Look At Forvia (ENXTPA:FRVIA) Valuation After The Recent Chairman Transition

Why this board change matters for Forvia investors Forvia (ENXTPA:FRVIA) drew fresh attention after its June 4 combined general meeting, where Pierre-André de Chalendar joined the Board for four years and was immediately elected Chairman following Michel de Rosen’s resignation. Alongside this leadership transition, the company also recently reported its total voting rights and share count as of May 31, 2026, giving investors an up to date view of ownership structure and governance. See our...
ENXTPA:SCR
ENXTPA:SCRInsurance

SCOR (ENXTPA:SCR) Valuation Check After Q1 Underwriting Beat And Lower Catastrophe Claims

SCOR (ENXTPA:SCR) has drawn fresh attention after first quarter results exceeded analyst expectations on non life underwriting, helped by relatively low catastrophe claims, even as renewal premiums declined across several reinsurance lines. See our latest analysis for SCOR. SCOR’s first quarter underwriting surprise has come alongside relatively steady share price momentum, with the 90 day share price return of 3.60% and year to date share price return of 8.30%. The 5 year total shareholder...
ENXTPA:BB
ENXTPA:BBCommercial Services

Assessing Société BIC (ENXTPA:BB) Valuation As Growth Slows And Multiples Look Stretched

Why Société BIC (ENXTPA:BB) is on investors’ radar Société BIC (ENXTPA:BB) has drawn attention after recent share price moves, with the stock last closing at €55.50 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Société BIC. At €55.50, Société BIC’s recent share price pullback over the past week and month sits against a year to date share price return of 7.56% and a 1 year total shareholder return of 5.04%. This suggests momentum has cooled...
ENXTPA:FGR
ENXTPA:FGRConstruction

Eiffage (ENXTPA:FGR) Valuation Check After New Campus AI And Nuremberg Infrastructure Contracts

Eiffage (ENXTPA:FGR) stock has been reacting to fresh contract wins after Campus AI selected the group to build a high voltage substation at its Fouju campus, alongside a separate bridge replacement project in Nuremberg. See our latest analysis for Eiffage. At a share price of €124.95, Eiffage’s stock has inched higher over the year to date, with a 1-year total shareholder return of 8.14% and a 5-year total shareholder return of 66.38%. However, the 30-day share price return declined 12.44%,...
ENXTPA:EXA
ENXTPA:EXAAerospace & Defense

A Look At Exail Technologies (ENXTPA:EXA) Valuation After Strong Revenue Momentum And Fresh DCF Signals

Exail Technologies (ENXTPA:EXA) is back in focus after fresh financials showed Q1 2026 revenue of €131 million versus €94 million a year earlier, along with an updated discounted cash flow analysis flagging potential undervaluation. See our latest analysis for Exail Technologies. The latest move in Exail Technologies' share price has been choppy, with the stock down 1.49% over the last day and 8.28% over the past week, yet still showing a 54.88% year to date share price return and a very...
ENXTPA:BNP
ENXTPA:BNPBanks

Is BNP Paribas (ENXTPA:BNP) Still Attractive After Strong Multi‑Year Share Price Gains?

Wondering if BNP Paribas at €93.65 is still offering value or if most of the easy gains are already behind it? This article walks through the numbers so you can judge for yourself. The stock has returned 0.8% over the last week, 0.3% over the last month, 14.3% year to date and 27.6% over the past year, with longer term returns of 102.0% over three years and 137.4% over five years putting recent moves into context. Recent coverage of BNP Paribas in broader market commentary has focused on how...
ENXTPA:TTE
ENXTPA:TTEOil and Gas

TotalEnergies Russian LNG Exit And US Wind Dispute Reshape Growth Options

TotalEnergies (ENXTPA:TTE) has received Russian approval to exit the U.S. sanctioned Arctic LNG 2 project, unwinding its 10% stake. Seven U.S. states have launched legal action over a Trump era agreement tied to the company’s withdrawal from new offshore wind projects in the U.S. Both developments center on long term energy policy, sanctions, and the balance between fossil fuels and renewables in TotalEnergies’ portfolio. TotalEnergies is a large integrated energy company with oil, gas, and...
ENXTPA:OR
ENXTPA:ORPersonal Products

A Look At L'Oréal (ENXTPA:OR) Valuation After CeraVe Benzene Lawsuits Raise Product Safety Concerns

Multiple class action lawsuits targeting CeraVe acne products have thrust L'Oréal (ENXTPA:OR) into the spotlight, prompting investors to reassess product safety risks, potential legal liabilities, and how these might influence sentiment toward the stock. See our latest analysis for L'Oréal. Recent share price moves suggest sentiment is steady rather than surging, with a 1-day share price return of 1.24% and a 1-year total shareholder return of 0.40%. Multi year total shareholder returns...
ENXTPA:CAP
ENXTPA:CAPIT

Did HMRC’s AI Customer-Service Overhaul Just Shift Capgemini’s (ENXTPA:CAP) Investment Narrative?

In recent months, HM Revenue & Customs announced a multi-year agreement with Capgemini, NiCE and Route 101 to modernise its customer service systems and expand digital self-service and AI-enabled support for UK taxpayers. This win underscores Capgemini’s growing role as a core digital transformation partner for large public-sector clients, especially in cloud, data and AI-led service delivery. Next, we’ll examine how this HMRC customer-service modernisation contract could influence...
ENXTPA:IPN
ENXTPA:IPNPharmaceuticals

How Investors Are Reacting To Ipsen (ENXTPA:IPN) Expanding IQIRVO Evidence In Primary Biliary Cholangitis

In May 2026, Ipsen reported new late-breaking Phase III and real-world data at the European Association for the Study of the Liver congress showing IQIRVO improved fatigue, pruritus and key biochemical markers in primary biliary cholangitis, with a tolerability profile consistent with earlier studies. The results further underline IQIRVO’s role as a differentiated second-line option in PBC, backed by both controlled trials and real-world evidence across multiple countries. We’ll now examine...
ENXTPA:SESG
ENXTPA:SESGMedia

Assessing SES (ENXTPA:SESG) Valuation After New Viva Inflight Connectivity Antenna Deal

SES and Viva expand inflight connectivity with new ESA antenna rollout SES (ENXTPA:SESG) is in focus after announcing a partnership with Viva to equip 100 Airbus aircraft with its multi orbit satellite inflight connectivity service, using a new low profile electronically steered array antenna. See our latest analysis for SES. The Viva agreement lands at a time when SES’s 90 day share price return of 39.09% and year to date share price return of 45.82% point to building momentum, while the 1...
ENXTPA:ENGI
ENXTPA:ENGIIntegrated Utilities

A Look At Engie’s (ENXTPA:ENGI) Valuation After Its €1,033 Million Green Financing Deal

Why Engie’s new green financing matters for shareholders Engie (ENXTPA:ENGI) has secured a €1,033 million export financing facility under Germany’s Green Shopping Line, a funding move directly tied to the company’s renewable build out and diversification of funding sources. See our latest analysis for Engie. Recent price action has been steady rather than dramatic, with the share price up 1.3% over the past day and 1.8% over the week, while the 1 month share price return is down 2.3%. Even...
ENXTPA:RCO
ENXTPA:RCOBeverage

Remy Cointreau (ENXTPA:RCO) Margin Compression To 8.4% Reinforces Bearish Narratives

Rémy Cointreau (ENXTPA:RCO) has reported its FY 2026 first half with revenue of €489.6 million and basic EPS of €1.22, setting the tone for how the rest of the year could shape up for shareholders. Over recent reporting periods, the company has seen revenue move from €533.7 million in FY 2025 first half to €450.9 million in FY 2025 second half and then to €489.6 million in FY 2026 first half, while basic EPS shifted from €1.81 to €0.56 and then to €1.22. This gives investors a clear view of...
ENXTPA:STMPA
ENXTPA:STMPASemiconductor

STMicroelectronics Backs Quobly To Bring Quantum Chips Into Its Fabs

STMicroelectronics (ENXTPA:STMPA) is co-leading a sizeable Series A funding round in Quobly, a company focused on silicon-based quantum computing. The partnership targets commercialization of quantum hardware by 2026, using ST's 300mm silicon fabrication facilities. The move extends ST's role in advanced semiconductors into quantum processors, with a focus on industrial scale production. STMicroelectronics, a major European semiconductor company active in automotive, industrial, and...
ENXTPA:TTE
ENXTPA:TTEOil and Gas

Is TotalEnergies (ENXTPA:TTE) Still Undervalued After Its Strong Recent Shareholder Returns

Why TotalEnergies (ENXTPA:TTE) Is Back On Investors’ Radar TotalEnergies (ENXTPA:TTE) has drawn fresh attention after recent trading, with the stock closing at €77.37. Investors are weighing this price against the company’s earnings profile, revenue mix and recent share performance. See our latest analysis for TotalEnergies. The recent move to €77.37 comes after a steady build in momentum, with a 7 day share price return of 2.91% and a year to date share price return of 37.91%. The 1 year...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

A Look At Sanofi (ENXTPA:SAN) Valuation After Venglustat Priority Review And Expanded AI Push

Why Sanofi’s latest drug and AI updates matter for the stock The recent priority review for Sanofi (ENXTPA:SAN) venglustat in type 3 Gaucher disease, together with its expanded AI partnership with Owkin, has pushed the stock back into focus for many investors. See our latest analysis for Sanofi. Sanofi’s €76.44 share price has picked up in the near term, with a 1 day share price return of 3.97% and a 1 month share price return of 3.07%. This is occurring even though the 1 year total...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

Airbus (ENXTPA:AIR) Valuation After New A350‑1000ULR Milestone And Fresh Long‑Haul Order Momentum

Airbus (ENXTPA:AIR) is back in focus after regulators moved to widen an airworthiness directive on main landing gear door actuators across A320 family jets, adding costs and compliance work for airlines operating nearly 2,000 affected aircraft. See our latest analysis for Airbus. Against a backdrop of fresh aircraft orders and high profile programs like Qantas’ A350-1000ULR and United’s first A321XLR, Airbus’ share price has recently rebounded with a 1 day share price return of 4.55% to...
ENXTPA:GET
ENXTPA:GETInfrastructure

Getlink (ENXTPA:GET) Valuation Check After Shuttle Traffic Update And Dividend Decision

Getlink (ENXTPA:GET) has drawn fresh attention after reporting May shuttle traffic figures alongside AGM outcomes, including a €0.80 per share dividend for 2025 and changes to board composition aligned with the Women on Boards Directive. See our latest analysis for Getlink. The latest traffic update and dividend decision come after a mixed price pattern, with the share price down 3.5% over the past month but showing a 14.8% year to date share price return and a 16.5% one year total...
ENXTPA:MLHK
ENXTPA:MLHKAerospace & Defense

Assessing H&K (ENXTPA:MLHK) Valuation After Q1 2026 Earnings Growth And Dividend Confirmation

Q1 earnings event and dividend decision H&K (ENXTPA:MLHK) is back in focus after reporting first quarter 2026 results, with sales of €128.1 million and net income of €20.1 million, alongside confirmation of an annual €0.06 dividend per share. See our latest analysis for H&K. The recent Q1 earnings and dividend confirmation have put H&K back on investors' radar, but the stock price tells a different story, with the year to date share price return down 25% and the 1 year total shareholder...